Search results
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters via AOL· 20 hours ago(Reuters) -Novavax on Friday said it had struck a licensing deal worth at least $1.2 billion with...
French, US drug firms team up for Covid-flu shot
Medical Xpress· 14 hours agoUnder a licensing deal worth up to $1.2 billion, the companies will co-commercialize Novavax's COVID-19 vaccine worldwide, except in some countries...
Novavax’s 146% Surge Delivers ‘Rib-Crunching’ Squeeze to Shorts
Bloomberg· 10 hours agoHave a confidential tip for our reporters? Novavax Inc.’s record one-day gain is forcing some short...
Why Novavax Stock More Than Doubled Today | The Motley Fool
The Motley Fool· 9 hours agoNovavax (NVAX 99.34%) are up 12% as of midday Friday following the release of the drugmaker's...
These Stocks Moved the Most Today: Novavax, Akamai, Sweetgreen, Taiwan Semi, Moderna, Gen Digital,...
Barrons.com· 6 hours agoNovavax stock surged after the vaccine maker signs a $1.2 billion licensing deal with France’s...
French, US drug firms team up for Covid-flu shot
AFP via Yahoo Finance· 16 hours agoFrench pharmaceutical giant Sanofi and struggling US rival Novavax announced Friday an alliance to sell a Covid vaccine and develop another that combines...
Novavax Stock More Than Doubles On Deal With Sanofi To Co-commercialize Covid-19 Vaccine
RTT News· 13 hours agoNovavax also announced a co-exclusive licensing agreement with Sanofi to co-commercialize Covid-19 vaccine and develop Novel Covid-19-Influenza combination ...
The Sanofi-Novavax vaccine deal is worth up to $1.2 billion
The Port Lavaca Wave· 12 hours agoThe Sanofi-Novavax vaccine deal is worth up to $1.2 billion
NVAX Stock Alert: Novavax Just Hit a New 52-Week High
InvestorPlace· 9 hours agoNovavax (NASDAQ:NVAX) stock investors are celebrating on Friday as the vaccine company’s shares hit...
Biotech Rockets 125% On Sanofi Covid Vaccine Agreement
Investor's Business Daily· 11 hours agoNovavax shares shot more than 125% higher Friday on news of a Covid-19 vaccine licensing agreement...